Zentalis Pharmaceuticals Statistics
Total Valuation
ZNTL has a market cap or net worth of $154.75 million. The enterprise value is -$82.57 million.
Important Dates
The next estimated earnings date is Wednesday, March 25, 2026, after market close.
| Earnings Date | Mar 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ZNTL has 64.75 million shares outstanding. The number of shares has increased by 1.13% in one year.
| Current Share Class | 64.75M |
| Shares Outstanding | 64.75M |
| Shares Change (YoY) | +1.13% |
| Shares Change (QoQ) | +0.20% |
| Owned by Insiders (%) | 1.75% |
| Owned by Institutions (%) | 58.28% |
| Float | 46.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.87 |
| Forward PS | n/a |
| PB Ratio | 0.71 |
| P/TBV Ratio | 0.62 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.76, with a Debt / Equity ratio of 0.16.
| Current Ratio | 7.76 |
| Quick Ratio | 7.55 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -49.18% and return on invested capital (ROIC) is -27.60%.
| Return on Equity (ROE) | -49.18% |
| Return on Assets (ROA) | -24.51% |
| Return on Invested Capital (ROIC) | -27.60% |
| Return on Capital Employed (ROCE) | -52.58% |
| Weighted Average Cost of Capital (WACC) | 10.91% |
| Revenue Per Employee | $161,837 |
| Profits Per Employee | -$899,494 |
| Employee Count | 166 |
| Asset Turnover | 0.07 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -205,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.16% in the last 52 weeks. The beta is 1.72, so ZNTL's price volatility has been higher than the market average.
| Beta (5Y) | 1.72 |
| 52-Week Price Change | +11.16% |
| 50-Day Moving Average | 2.34 |
| 200-Day Moving Average | 1.67 |
| Relative Strength Index (RSI) | 47.67 |
| Average Volume (20 Days) | 652,758 |
Short Selling Information
The latest short interest is 3.78 million, so 5.84% of the outstanding shares have been sold short.
| Short Interest | 3.78M |
| Short Previous Month | 4.03M |
| Short % of Shares Out | 5.84% |
| Short % of Float | 8.19% |
| Short Ratio (days to cover) | 1.65 |
Income Statement
In the last 12 months, ZNTL had revenue of $26.87 million and -$149.32 million in losses. Loss per share was -$2.08.
| Revenue | 26.87M |
| Gross Profit | 26.87M |
| Operating Income | -152.53M |
| Pretax Income | -149.52M |
| Net Income | -149.32M |
| EBITDA | -151.63M |
| EBIT | -152.53M |
| Loss Per Share | -$2.08 |
Full Income StatementBalance Sheet
The company has $280.70 million in cash and $40.46 million in debt, with a net cash position of $240.24 million or $3.71 per share.
| Cash & Cash Equivalents | 280.70M |
| Total Debt | 40.46M |
| Net Cash | 240.24M |
| Net Cash Per Share | $3.71 |
| Equity (Book Value) | 252.87M |
| Book Value Per Share | 3.50 |
| Working Capital | 251.13M |
Full Balance SheetCash Flow
| Operating Cash Flow | -134.01M |
| Capital Expenditures | n/a |
| Free Cash Flow | -134.01M |
| FCF Per Share | -$2.07 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -567.77% |
| Pretax Margin | -556.56% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ZNTL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.13% |
| Shareholder Yield | -1.13% |
| Earnings Yield | -94.70% |
| FCF Yield | -84.99% |
Analyst Forecast
The average price target for ZNTL is $6.60, which is 176.15% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.60 |
| Price Target Difference | 176.15% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 26.45% |
| EPS Growth Forecast (5Y) | -37.99% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ZNTL has an Altman Z-Score of -4.29 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.29 |
| Piotroski F-Score | 2 |
